Feasibility of randomizing Danish citizens aged 65–79 years to high-dose quadrivalent influenza vaccine vs. standard-dose quadrivalent influenza vaccine in a pragmatic registry-based setting: rationale and design of the DANFLU-1 Trial

BACKGROUND: High-dose influenza vaccines provide better protection against influenza infection than standard-dose in persons aged 65 years and above; however, in most countries, high-dose vaccines are not widely implemented. Assessing the relative effectiveness of high-dose compared to standard-dose...

Descripción completa

Detalles Bibliográficos
Autores principales: Johansen, Niklas Dyrby, Modin, Daniel, Nealon, Joshua, Samson, Sandrine, Salamand, Camille, Larsen, Carsten Schade, Claggett, Brian L., Solomon, Scott D., Landray, Martin J., Gislason, Gunnar H., Køber, Lars, Jensen, Jens Ulrik Stæhr, Sivapalan, Pradeesh, Vestergaard, Lasse Skafte, Valentiner-Branth, Palle, Krause, Tyra Grove, Biering-Sørensen, Tor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022021/
https://www.ncbi.nlm.nih.gov/pubmed/35449028
http://dx.doi.org/10.1186/s40814-022-01044-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022021/
https://www.ncbi.nlm.nih.gov/pubmed/35449028
http://dx.doi.org/10.1186/s40814-022-01044-w

Ejemplares similares